TB

Tapash Barooah

Active Director Director DIN 10113074
DIN 10113074 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Tapash Barooah

Data last updated:

Tapash Barooah is a Director at Renascent Pharma Private Limited (since 2023). Renascent Pharma Private Limited reported revenue of ₹55.5 Lakh (FY 2025).

DIN 10113074
Primary Designation Director
First Appointment 14 Mar 2023
Oldest Company Age 3 yrs
Largest company Renascent Pharma Private Limited · ₹55.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Renascent Pharma Private Limited U46901HR2023PTC109901
Director14 Mar 20232023₹55.5 Lakh (FY 2025)Active

Board colleagues of Tapash Barooah

NameDINCompanyDesignation
Suresh Singh Kr06737018Renascent Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Renascent Pharma Private Limited
Premium access

Shareholding and investment profile for Tapash Barooah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tapash Barooah

Tapash Barooah currently holds 1 directorship: Renascent Pharma Private Limited (Director, since 14 Mar 2023, revenue ₹55.5 Lakh (FY 2025)).

Tapash Barooah was first appointed on 14 Mar 2023 as Director at Renascent Pharma Private Limited.

The current boards of Tapash Barooah's companies include Suresh Singh Kr (Renascent Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available